Apple Halts Sales of Apple Watch Series 9 and Ultra 2 in the US Ahead of Pending Patent Ban

Apple has made the decision to stop selling the Apple Watch Series 9 and Ultra 2 in the US through its online store just days before a ban related to a patent dispute is set to take effect. In addition to this, Apple will also no longer be able to repair watch models that are out of warranty, which could potentially cause headaches for consumers who rely on Apple’s repair services.

Background on the sales ban

This sales ban was imposed by the US International Trade Commission (ITC) after it ruled that Apple had violated two health technology patents related to blood oxygen sensing. These patents are held by Masimo, a company based in Irvine, California. The ITC’s ruling highlights the significance of these patents in relation to Apple’s technology and the potential infringements.

Apple’s response to the ban

In response to the ban, Apple has posted a message on its website stating that it no longer sells Apple Watch units in the United States equipped with the ability to measure blood oxygen. This move signals Apple’s compliance with the ITC’s ruling and its efforts to avoid further legal complications.

Impact on watch repairs

Not only does the ban affect sales, but it also impacts Apple’s ability to repair out-of-warranty watch models. Apple will no longer replace these models going back to the Apple Watch Series 6. This decision has a wide-reaching impact, affecting most new Apple Watches sold since 2020, including Series 6, 7, 8, Ultra, and the current Series 9 and Ultra 2. Consumers who rely on Apple’s repair services may face difficulties in getting their out-of-warranty watches fixed.

Limitations on customer options

In addition to the restrictions on repairs, customers will also face limitations on their options regarding watch exchanges. After December 25, when the ban comes into effect, Apple will not allow customers to exchange watches purchased before the ban for different colors or sizes during the typical return period. This restriction may frustrate customers who wish to switch their watches or match them with their personal preferences.

Communication restrictions for employees

To comply with the legal order, Apple has informed its employees that they are prohibited from informing customers that the Apple Watch is still available for purchase at third-party retailers like Best Buy and Target. This restriction on communication aims to avoid further legal complications and ensure Apple’s compliance with the ban.

Duration and Potential Resolutions

The ban on the sale of Apple Watches equipped with blood oxygen measurement capabilities will remain in effect until Apple can reach a licensing agreement with Masimo, receive a federal reprieve, or successfully resolve the patent dispute. The duration of this ban is uncertain, and it will depend on the progress of negotiations or any legal actions taken by Apple.

Apple’s decision to halt the sales of the Apple Watch Series 9 and Ultra 2, as well as the limitation on out-of-warranty repairs, is a direct response to an upcoming ban resulting from patent infringements identified by the US International Trade Commission. Consumers who have purchased watches before the ban comes into effect and still have warranty coverage will not be affected, but others will face challenges in getting their watches repaired or exchanged. It is important for customers to be aware of these limitations and potential impacts on their Apple Watch purchases and repairs. Apple’s compliance with the ban demonstrates its commitment to resolving the patent dispute and finding a resolution with Masimo in the near future.

Explore more

ARPA-H Invests $32M in Autonomous Robotic Stroke Treatment

Redefining the Race: The Clock in Stroke Intervention When a blood clot suddenly lodges in a cerebral artery, the human brain begins to lose roughly two million neurons every single minute that the obstruction remains in place. This reality defines the urgency behind a $32 million investment from the Advanced Research Projects Agency for Health (ARPA-H). The funding targets Magnendo,

Guide Ranks the Best Small Business Payroll Software for 2026

The moment an entrepreneur realizes that a simple decimal error in a payroll run could trigger a massive federal audit is usually the exact second they stop viewing their software as a luxury and start seeing it as an essential protective shield. In the current landscape, the margin for error has narrowed significantly, as state and federal tax authorities have

Can AI Ever Replace Human Intuition in Modern Hiring?

A seasoned hiring manager tosses a candidate’s profile aside while claiming the person simply did not have the right energy, leaving a nearby data analyst completely baffled. To an advanced artificial intelligence, this feedback is a dead end—a vague data point that offers no actionable insight for a machine-learning model. To a veteran recruiter, however, this phrase is a coded

AI Hiring Tools Are Now a Major Security Risk for CIOs

The unassuming PDF file sitting in a digital stack of applications has quietly evolved from a static career summary into a sophisticated piece of executable code capable of hijacking enterprise logic. For decades, recruitment software lived in the relative safety of the back office, primarily serving as a repository for record-keeping and workflow automation. However, the rapid integration of artificial

AI and Remote Work Fuel a Costly Crisis in Hiring Integrity

The polished professional currently answering technical questions on a high-definition video call might actually be an elaborate digital facade powered by a sophisticated network of hidden AI agents. Recruitment processes that once relied on physical cues and verified histories have been subverted by a wave of technological deception that threatens the very core of corporate integrity. As organizations expanded their